HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Nava Morhedzadeh, Speaker at Nutrition Conferences
Kerman University of Medical Sciences, Iran (Islamic Republic of)


The present study aimed to evaluate the efficacy of flaxseed supplementation in the management of metabolic syndrome (MetS)-related parameters among the patients with mild-to-moderate ulcerative colitis (UC). A randomized controlled clinical trial was conducted on 70 patients with UC. Participants were randomized in the intervention group, which received 30 g/day ground flaxseed powder or control group. Anthropometric and biochemical variables were assessed at the beginning and end of 12 weeks of intervention. Of the 70 patients enrolled in this study, 64 subjects were included in the final analysis. From baseline to 12 weeks' intervention, flaxseed supplementation resulted in a significant reduction in the serum concentration of insulin (p < .001), HOMA-IR (p < .001), triglyceride (p = .001), total cholesterol (p < .001), and significant increase in the serum levels of HDL (p = .008). However, we not observed any significant differences between two groups regarding the body weight, BMI, waist circumferences, systolic, and diastolic blood pressure (p > .05). Overall, 12 weeks of flaxseed supplementation resulted in greater improvement in the some MetS-related parameters.


Dr. Nava Morshedzadeh is currently a member of the Faculty of Health, Kerman University of Medical Sciences as an assistant professor. Dr. Morshedzadeh completed his doctorate degree and doctoral thesis in 2018. Dr. Morshedzadeh's publications reflect his experience in systematic reviews as well as randomized controlled trials, which he has published in 20 articles and books on nutrition in gastrointestinal diseases.